Anti-WDR4 antibody [EPR11052]
- BOND RX™ Validated
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(3 Reviews)
|
(9 Publications)
Rabbit Recombinant Monoclonal WDR4 antibody. Suitable for WB, IHC-P, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 9 publications.
View Alternative Names
tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4, Protein Wuho homolog, WD repeat-containing protein 4, hWH, WDR4
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-WDR4 antibody [EPR11052] (AB169526)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human prostatic hyperplasia tissue sections labeling WDR4 with purified ab169526 at 1 : 1000 (1.026 μg/ml). Heat mediated antigen retrieval was performed using Bond™ Epitope Retrieval Solution 1 (pH 6.0). Tissue was counterstained with Hematoxylin. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used. PBS instead of the primary antibody was used as the negative control. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-WDR4 antibody [EPR11052] (AB169526)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human breast carcinoma tissue sections labeling WDR4 with purified ab169526 at 1 : 1000 (1.026 μg/ml). Heat mediated antigen retrieval was performed using Bond™ Epitope Retrieval Solution 1 (pH 6.0). Tissue was counterstained with Hematoxylin. Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used. PBS instead of the primary antibody was used as the negative control. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-WDR4 antibody [EPR11052] (AB169526)
Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labelling WDR4 with purified ab169526 at 1/100 dilution (10 µg/ml) (red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150081) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (black). Unlabelled control - Cell without incubation with primary antibody and secondary antibody (blue).
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-WDR4 antibody [EPR11052] (AB169526)
Immunocytochemistry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling WDR4 with purified ab169526 at 1 : 100 dilution (10.2 µg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1/200 dilution (2.5 µg/ml) (ab195889) (red). Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) was used as the secondary antibody at 1 : 1000 (2 µg/ml) dilution. DAPI (blue) was used as a nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- WB
Supplier Data
Western blot - Anti-WDR4 antibody [EPR11052] (AB169526)
All lanes:
Western blot - Anti-WDR4 antibody [EPR11052] (ab169526) at 1/1000 dilution
Lane 1:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
A549 (Human lung carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 45 kDa
Observed band size: 45 kDa
false
- WB
Unknown
Western blot - Anti-WDR4 antibody [EPR11052] (AB169526)
Lanes 1-3 : Merged signal (red and green). Green - ab169526 observed at 49 kDa. Red - loading control ab8245 observed at 36 kDa.
ab169526 Anti-WDR4 antibody [EPR11052] was shown to specifically react with WDR4 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265109 (knockout cell lysate ab258285) was used. Wild-type and WDR4 knockout samples were subjected to SDS-PAGE. ab169526 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-WDR4 antibody [EPR11052] (ab169526) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
WDR4 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human WDR4 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-wdr4-knockout-hela-cell-line-ab265109'>ab265109</a>)
Lane 3:
HepG2 cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 45 kDa
Observed band size: 49 kDa
false
Related conjugates and formulations (11)
-
Anti-WDR4 antibody [EPR11052] - BSA and Azide free
-
660 APC
APC Anti-WDR4 antibody [EPR11052]
-
HRP Anti-WDR4 antibody [EPR11052]
-
Alkaline Phosphatase Anti-WDR4 antibody [EPR11052]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-WDR4 antibody [EPR11052]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-WDR4 antibody [EPR11052]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-WDR4 antibody [EPR11052]
-
578 PE
PE Anti-WDR4 antibody [EPR11052]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-WDR4 antibody [EPR11052]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-WDR4 antibody [EPR11052]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-WDR4 antibody [EPR11052]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
WDR4 plays a role in the maintenance of accurate protein synthesis. It contributes to the stabilization and correct folding of tRNA molecules which are essential for the translation of genetic information from mRNA to proteins. As part of the tRNA methyltransferase complex WDR4 interacts with the METTL1 enzyme highlighting its involvement in precise tRNA modification processes critical for cellular function and proliferation.
Pathways
The function of WDR4 integrates into the broader landscape of the RNA modification pathway. This pathway is tied to the regulation of gene expression and cellular homeostasis. WDR4's activity impacts the efficiency and fidelity of the translation pathway. In this context WDR4 works closely with METTL1 enhancing the stability and functional capacity of tRNA during protein synthesis which is pivotal for the correct transmission of genetic code within cells.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Cancer medicine 14:e70992 PubMed40485623
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:378 PubMed40360483
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 14:1260195 PubMed37868988
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oncogenesis 12:47 PubMed37783676
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer 22:119 PubMed37516825
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature 613:391-397 PubMed36599985
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer communications (London, England) 42:223-244 PubMed35179319
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 11:1-14 PubMed34938908
2021
Applications
Unspecified application
Species
Unspecified reactive species
Haematologica 105:661-673 PubMed31289202
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com